世茂股份(600823.SH):週三已劃撥付息兌付資金3,135萬人幣
世茂股份(600823.SH)公佈,爲保證「2018年度第三期中期票據」2021年付息兌付工作的順利進行,公司於週三(15日)已向銀行間市場清算所指定固定收益產品,付息兌付資金帳戶足額劃撥付息兌付資金,付息兌付總金額爲3,135萬元人民幣(下同),用於兌付上述「2018年度第三期中期票據」,本次兌付完成後,該票據將全部結清。
「2018年度第三期中期票據」發行總額爲10億元。根據發行文件中相關條款規定,投資者於2020年12月17日行使回售選擇權,回售金額爲9.7億元,未回售金額爲3,000萬元,調整後票面利率爲4.5釐,計息期間爲2020年12月17日至2021年12月16日。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.